Among numerous immunologic alterations present in patients with lupus, the type I IFN system is thought to play a pivotal role in pathogenesis [36-38], which points to a possible role of UBE2L3. However, the exact mechanism of UBE2L3 is still not fully understood. This evidence concerns the gene UBE2L3 and systemic lupus erythematosus.